Join the SmallCapReview mailing list.

MYGN Myriad Genetics: A  personalized medicine company, that focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. MYGN has a collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx.    More.
AUPH Aurinia Pharmaceuticals: A late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need.  More. 
LPCN Lipocine Inc.: A specialty pharmaceutical company developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies. LPCN's clinical development pipeline includes three development programs.   More.
HISP Hispanica International: Is engaged in the distribution of proprietary, licensed and third party Hispanic and Ethnic food and beverages throughout the United States. The Company added over 1,400 retailers to now surpass 2,000 retail locations and will expand to over 5,000 retail locations. More.
Commentary

Small Cap Value Closes Performance Gap


Aurinia (AUPH) Receives National Corporate Visionary Award From From Lupus Foundation Of America


Here Are The Actual Tax Rates The Biggest Companies In America Pay


Small Caps To Benefit Most From Tax Reform


Small Caps Catch Fire On Tax Cut Plan


Markets
Volume Leaders
Advancers/Decliners
52 Week Highs/Lows
Small-Cap Index
Tools
Check Futures Here
Quotes
Level II Quotes
Stock Screener
Performance by Industry
Pre-Market
After Hours Market
World Markets
Education

 

Visit Our Resources Page

Past Articles Worth Reading

 

 

 

 


 

 

 

 

 

 

 Where Small Cap Stocks Thrive Since 1999                                           

Small Caps Rally On Tax Bill


Strong Earnings From Small Cap Cyclicals...

5 Microcaps Ready To Explode...

Small Cap Stocks Poised To Move Higher...

Advantages Of Small Cap Stocks...

Is This A Buying Opportunity In Small Caps?

Small Cap Stocks Have Been On Fire...

Small Cap Quality Shines Through...

Aurinia (AUPH) To Expand Renal Franchise With Novel Indications And Launches Development Program For Dry Eye Syndrome...

Why High Flying Aurinia Pharmaceuticals (AUPH) Could Still be Dirt Cheap...

Small Cap Euphoria...

8 Strategies For Picking Small Caps...

The Small Cap Rush...

The Re-emergence Of Small Cap Stocks...

The Best Performing Part Of The Market Right Now Is Microcaps...

Small Caps To Watch...

Small Cap IR By The Numbers... Average Small Cap IR budget: $224,000, with $78,000 spent on external services.


Lipocine (LPCN)

Website: www.Lipocine.com

"Developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies."

More on LPCN here...


Myriad Genetics (MYGN)

Website: www.Myriad.com

"Myriad has the deepest diagnostic pipeline across the disease spectrum."

More on MYGN here...


Aurinia Pharmaceuticals (AUPH)

 

Website: www.Auriniapharma.com

"Voclosporin has the potential to become a best in class medication and the first approved treatment for LN in the U.S. and Europe."

More on AUPH here...


Hispanica International (HISP)

Website: www.Hidainc.com

"We Bring Latin America And The World To You."

More on HISP here...


Follow Us On

Twitter


Why Aurinia Pharmaceuticals (AUPH) Could Be A Gold Mine For Growth Investors


Small Cap Puzzling Breakout Is Back On Track


Your Five Point Investing Guide For This Aging Bull Market


Value Stocks Cheapest Since 2000


A World Of Small Cap Opportunities


How To Play The 'Small Cap Effect'


Is The Tide Turning In Small Cap And Microcaps' Favor?


3 Reasons To Buy Aurinia Pharmaceuticals (AUPH) Right Now


5 Small Caps For The Rest Of 2017


Top 7 Small Caps Likely To Reach $10 Billion Market Cap


13 Small Caps That Could Shine


Time To Avoid Staple Stocks And Seek Growth In Small Caps


It's Time To Go Large In Small Caps


What Is The S&P Small Cap 600?


Why You Should Be Buying Small Caps


Why It's Time For Small Caps To Shine


Small Caps Shake Off Summer Blues


Small Caps Take Bump From Fed


Small Caps Rally On Hopes Of Tax Deal


Bristol Myers Teams Up With Small Cap


Where Are We In The Small Cap Cycle?


The Case For Small Caps Post Harvey


Small Caps: The Easy Game For Active Managers


What Makes Small Caps Mighty And Risky


3 Small Caps With Sizeable Dividends


10 Hidden Gem Small Cap Stocks


Small Cap Picks For Big Gain


7 Small Cap Stocks With Big League Potential



Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks via email. You can sign-up here.


"A Primer In Small Cap Investing"

SmallCapReview.com® is a leading destination for small-cap picks and news. The Purpose of SmallCapReview.com is to profile and bring awareness to companies with a market cap of less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap stocks to watch via various newswires. We will strive to bring you the undiscovered, the undervalued, and the oversold. SmallCapReview.com does not give "buy" recommendations, price targets nor suggest entry and exit points.

"A Look at Small Cap Stocks that may no longer be Small Caps"


 

 

 


 
© 1999-2017 SmallCapReview.com. Any questions or comments regarding this site should be directed to editor@smallcapreview.com